Published in Cancer Res on July 01, 1994
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol (1999) 2.88
Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut (2006) 1.42
Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol (1998) 1.36
Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol (2000) 1.20
Molecular biology of Barrett's adenocarcinoma. Ann Surg (2001) 1.17
Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family history. Am J Pathol (1995) 1.15
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features. PLoS One (2008) 1.12
Microsatellite instability in ovarian neoplasms. Br J Cancer (1995) 1.06
Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am J Pathol (1996) 1.00
The cumulative effects of polymorphisms in the DNA mismatch repair genes and tobacco smoking in oesophageal cancer risk. PLoS One (2012) 0.99
Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue. Clin Cancer Res (2008) 0.99
Microsatellite instability in inflamed and neoplastic epithelium in ulcerative colitis. J Clin Pathol (2001) 0.97
Infrequent microsatellite instability in oesophageal cancers. Br J Cancer (1997) 0.97
Malignant transformation of non-neoplastic Barrett's epithelial cells through well-defined genetic manipulations. PLoS One (2010) 0.95
Rab11 in dysplasia of Barrett's epithelia. Yale J Biol Med (2000) 0.90
Microsatellite instability in preinvasive and invasive head and neck squamous carcinoma. Am J Pathol (1996) 0.88
DNA mismatch repair gene mutations in human cancer. Environ Health Perspect (1997) 0.85
Microsatellite instability in human testicular germ cell tumours. Br J Cancer (1995) 0.83
Passenger mutations as a marker of clonal cell lineages in emerging neoplasia. Semin Cancer Biol (2010) 0.83
Mini- and microsatellites. Environ Health Perspect (1997) 0.81
Differences in genetic instability and cellular phenotype among Barrett's, cardiac, and gastric intestinal metaplasia in a Japanese population with Helicobacter pylori. Histopathology (2009) 0.80
Variability in the interpretation of microsatellite patterns with different electrophoretic conditions. Mol Pathol (1999) 0.80
Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma. Br J Cancer (1995) 0.80
Aneuploid human colonic epithelial cells are sensitive to AICAR-induced growth inhibition through EGFR degradation. Oncogene (2012) 0.77
Early genetic instability of both epithelial and stromal cells in esophageal squamous cell carcinomas, contrasted with Barrett's adenocarcinomas. J Gastroenterol (2007) 0.76
HLA-B*27 typing by sequence specific amplification without DNA extraction. Mol Pathol (1999) 0.75
Loss of heterozygosity and microsatellite instability as predictive markers among Iranian esophageal cancer patients. Iran J Basic Med Sci (2016) 0.75
Barrett's esophagus: model of neoplastic progression. World J Surg (2003) 0.75
Genetic control of the cell division cycle in yeast. Science (1974) 13.83
An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc Natl Acad Sci U S A (1985) 6.00
An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology (1993) 5.41
A p53-dependent mouse spindle checkpoint. Science (1995) 4.01
Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol (2008) 3.80
Regulation of mating in the cell cycle of Saccharomyces cerevisiae. J Cell Biol (1977) 3.68
Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet (1999) 3.30
Extensive editing of the cytochrome c oxidase III transcript in Trypanosoma brucei. Cell (1988) 3.26
Genetic analysis of the phase variation control of expression of type 1 fimbriae in Escherichia coli. J Bacteriol (1985) 2.62
The borderline cervical smear. Cytopathology (1995) 2.60
17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci U S A (1996) 2.53
Particulate matter in the atmosphere: which particle properties are important for its effects on health? Sci Total Environ (2000) 2.50
PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet (1997) 2.44
The use and abuse of population viability analysis. Trends Ecol Evol (2001) 2.40
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med (1996) 2.37
Colposcopic assessment of the accuracy of cervical cytology screening. Br Med J (Clin Res Ed) (1988) 2.22
Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol (2001) 2.21
The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J Cell Sci (2000) 2.21
Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet (1996) 2.19
Bronchial rupture by a double-lumen endobronchial tube during staging thoracoscopy. Anesth Analg (1999) 2.16
Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology (1987) 2.15
Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res (2000) 2.13
Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res (1999) 2.09
p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res (2001) 2.06
E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst (2000) 2.05
Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med (2000) 2.05
Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology (1992) 2.03
CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res (2001) 1.92
Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol (1986) 1.91
Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR. Genome Res (1999) 1.90
The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur J Cancer (2002) 1.88
Transposition mutagenesis of bacteriophage lambda: a new gene affecting cell lysis. J Mol Biol (1979) 1.87
Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest (1989) 1.83
Sulphasalazine and male infertility: reversibility and possible mechanism. Gut (1981) 1.80
Computation, prediction, and experimental tests of fitness for bacteriophage T7 mutants with permuted genomes. Proc Natl Acad Sci U S A (2000) 1.78
Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci U S A (1995) 1.75
The inducibly expressed GTPase localizes to the endoplasmic reticulum, independently of GTP binding. J Biol Chem (1997) 1.75
Hyperammonaemia: a deficiency of liver ornithine transcarbamylase. Occurrence in mother and child. Arch Dis Child (1969) 1.74
Establishing a community network for recruitment of African Americans into a clinical trial. The African-American antiplatelet stroke Prevention Study (AAASPS) experience. J Natl Med Assoc (1996) 1.68
p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res (1997) 1.67
Superior sulcus (Pancoast) tumor: experience with 105 patients. Ann Thorac Surg (1998) 1.67
Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord (2004) 1.66
Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res (1992) 1.65
Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene (2000) 1.63
Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction. Proc Natl Acad Sci U S A (1991) 1.62
Pancreatic insufficiency and neutropenia with associated immunoglobulin deficit. Arch Intern Med (1970) 1.61
p53-mutant clones and field effects in Barrett's esophagus. Cancer Res (1999) 1.61
Effectiveness of early physical therapy in the treatment of acute low back musculoskeletal disorders. J Occup Environ Med (2000) 1.59
Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology (1997) 1.59
Mast cells promote lung vascular remodelling in pulmonary hypertension. Eur Respir J (2010) 1.57
Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol Cell Biol (1999) 1.56
Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A (1992) 1.56
Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. Oncogene (2006) 1.55
Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays. Oncogene (2002) 1.54
Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg (1997) 1.53
Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc Natl Acad Sci U S A (1991) 1.53
17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res (1994) 1.52
Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Res (2001) 1.52
Thoracoscopic management of spontaneous pneumothorax. Chest (1992) 1.50
Phase I/II study of vaccination with dendritic-like leukaemia cells for the immunotherapy of acute myeloid leukaemia. Br J Haematol (2006) 1.48
Search for a primary lung neoplasm in patients with brain metastasis: is the chest radiograph sufficient? AJR Am J Roentgenol (1997) 1.48
Case 6-5--1992. Anesthetic considerations for thoracoscopic procedures. J Cardiothorac Vasc Anesth (1992) 1.47
Intracellular kinetics of a growing virus: a genetically structured simulation for bacteriophage T7. Biotechnol Bioeng (1997) 1.46
Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene (1996) 1.46
Detection of evolving viruses. Nat Biotechnol (1996) 1.46
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst (2000) 1.45
Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst (1999) 1.44
The six-minute walk test in healthy children: reliability and validity. Eur Respir J (2005) 1.44
p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology (1994) 1.43
The use of concurrent chemotherapy with high-dose radiation before surgical resection in patients presenting with apical sulcus tumors. Cancer J (2000) 1.43
A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms. Gastroenterology (1997) 1.42
Sotos' syndrome of cerebral gigantism. Arch Dis Child (1969) 1.41
Simple, efficient catalyst system for the palladium-catalyzed amination of aryl chlorides, bromides, and triflates. J Org Chem (2000) 1.40
Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci U S A (1993) 1.40
Small cell lung cancer treated in southeast Wales. Clin Oncol (R Coll Radiol) (2006) 1.40
17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Cancer Res (1991) 1.39
Hyperglycemia-induced small intestinal dysrhythmias attributed to sympathovagal imbalance in normal and diabetic rats. Neurogastroenterol Motil (2015) 1.39
Growth suppression of esophageal cancer cells by p16INK4 and p15INK4B in vitro. Cancer J Sci Am (2006) 1.39